Cd4-specific antibody trx1 and uses therefor

Details for Australian Patent Application No. 2008229990 (hide)

Owner Tolerrx Inc. Cambridge University Technical Services Limited ISIS Innovation Limited

Inventors Gorman, Scott; Windsor-Hines, Dawn; Waldmann, Herman; Rao, Patricia; Cobbold, Stephen; Ringler, Douglas; Hale, Geoff; Kornaga, Tadeusz; Frewin, Mark

Agent Griffith Hack

Pub. Number AU-A-2008229990

Parent 2002302848

Filing date 17 October 2008

Wipo publication date 6 November 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/73 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

Event Publications

6 November 2008 Application Open to Public Inspection

  Published as AU-A-2008229990

6 November 2008 Complete Application Filed

22 April 2010 Alteration of Name

  The name of the applicant has been altered to Tolerx Inc.; Cambridge University Technical Services Limited; ISIS Innovation Limited

8 July 2010 Alteration of Name

  The name of the applicant has been altered to Tolerx Inc.; ISIS Innovation Limited; Cambridge Enterprise Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008229991-Analysis, management and assignment of insurable events

2008229989-Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions